Vigyata.AI
Is this your channel?

[Ep 8] 🌟 Ideas turns into Reality 👁️| Prof Jodhbir S Mehta| SNEC x MEDI.CUE

156 views· 4 likes· 6:14· Sep 27, 2023

#ophthalmology #medicine @sgh In this episode, we discussed how Prof Jod went through design to producing essential surgical instruments for corneal transplants Stay tuned for more episodes! Who is Professor Jodhbir S Mehta? Professor Mehta is the Head and Senior Consultant of the Corneal and External Eye Disease Department at SNEC, and the Executive Director of SERI. He is also a full tenured Professor at Duke-NUS Medical School. Professor Mehta is key in the translational clinical research program on innovations in tissue engineering of selective corneal cell layers for corneal transplantation. ❤️Big thanks to Singapore National Eye Centre Singapore General Hospital Duke NUS Medical School 📸 My Instagram -[https://www.instagram.com/medi.cue/] 🐦 My Facebook- [https://www.facebook.com/Medi.CUe23] 📕 My Email- medi.cue23@gmail.com 👨🏼‍ 👨🏼‍⚕️ WHO AM I? I'm King, a medical graduate from The Chinese University of Hong Kong. I make videos about admission interviews and my medical journey in Hong Kong.

About This Video

In this Episode 8 at SNEC x MEDI.CUE, I sat down with Prof Jodhbir S Mehta and asked him about something that honestly still blows my mind—how we can take an ultra-thin corneal graft (the kind I watched him insert during a corneal transplant) and deliver it safely into the eye through such a small incision. I told him I was mesmerized by how the tissue folds into the inner layer, and he broke down the “ideas into reality” process behind designing real surgical instruments for DSAEK/DMEK. What I took away is how practical innovation can be when you start from first principles. Prof Jod explained the core challenge—getting an 8 mm graft through a 5 mm (and later 2.7 mm) incision—and how brainstorming (even with non-ophthalmology friends) can lead to elegant solutions. He shared the development of the EndoGlide (first sold around 2009 as one of the early FDA-approved devices for corneal transplantation), and the data showing significantly less endothelial cell damage compared to forceps delivery (he quoted ~60% improvement). As techniques evolved to thinner, more fragile DMEK tissue, he redesigned forceps (e.g., 27-gauge) and even the chamber maintainer flow to reduce graft movement. The bigger message: make surgery easier, teach it properly, publish, and share—because the end goal is more surgeons adopting a technique that helps patients.

Frequently Asked Questions

🎬 More from Medicue